IL6 and cancer: As described previously [19], measurement of systemic biomarker concentrations revealed statistically significant increases (p < 0.05) in all of the following biomarkers in the group of cancer patients relative to controls: blood platelets, NLR, PLR, SII, CRP, IL-6, IL-8, and TNFα.